HOME THERAPY AREAS GC tapering for patients receiving avacopan 29 January 2026 Nephrology and Rare Diseases ANCA-associated vasculitis GC tapering for patients receiving avacopan Summary of available evidence on the approach to GC tapering from clinical studies, guidelines, expert opinions and RWEExplore the strategies and guidance for GC tapering when using an avacopan-based regimen View PDF